Menu
- Home
+ - Publications
+
- Archives
+
- BCIQ
+
- Conferences
+
- eLearning
+
- Follow Us
Latest News
4:20 PM May 25, 2018
China rare disease list could promote R&D, regulatory filings
Five Chinese government agencies, including the State Drug Administration and the National Health...
3:48 PM May 25, 2018
NEA promotes Chang, Behbahani
New Enterprises Associates promoted Carmen Chang and partner Ali Behbahani to general partner. Chang, a...
3:48 PM May 25, 2018
Management tracks: ISA, ImCheck, ArQule
Immunotherapy company ISA Pharmaceuticals B.V. (Leiden, the Netherlands) promoted CBO Gerben Moolhuizen to...
3:08 PM May 25, 2018
Eidos, Avrobio propose NASDAQ IPOs
Eidos Therapeutics Inc. (Palo Alto, Calif.) and Avrobio Inc. (Cambridge, Mass.) proposed NASDAQ IPOs on...
2:59 PM May 25, 2018
Activating astrocytes to enhance memory
In a paper published in Cell, researchers at The Hebrew University of Jerusalem showed that activating...
2:21 PM May 25, 2018
Chinese investors launch HPV JV
Shanghai Institute of Biological Products Co. Ltd. (Shanghai, China), 6 Dimensions Capital and Renxian...
2:08 PM May 25, 2018
Immunoproteasome company Kezar files for $80.5M IPO
Kezar Life Sciences (South San Francisco, Calif.) filed Thursday to raise $80.5 million in an IPO on...
1:07 PM May 25, 2018
Venter retiring from Human Longevity
J. Craig Venter said in a tweet May 24 that he is retiring from genomics company Human Longevity Inc. (San...
11:52 AM May 25, 2018
Monitoring the gut with engineered biosensor
A Science study led by Senti Biosciences Inc. (South San Francisco, Calif.) co-founder and CEO Timothy Lu...
11:35 AM May 25, 2018
Imfinzi shows OS benefit in non-progressing NSCLC trial
AstraZeneca plc (LSE:AZN; NYSE:AZN) said Imfinzi durvalumab improved overall survival vs. placebo, meeting...
10:53 AM May 25, 2018
AI-based diagnostic for wrist fractures gets FDA green light
FDA has permitted marketing of OsteoDetect, an artificial intelligence-based software product from Imagen...
10:05 PM May 24, 2018
Transplant company Magenta plans $100M listing
Stem cell transplant company Magenta Therapeutics Inc. (Cambridge, Mass.) filed to raise up to $100...
7:27 PM May 24, 2018
Anti-infectives play Iterum raises $80M in IPO
Iterum Therapeutics plc (NASDAQ:ITRM) raised $80 million late Thursday through the sale of 6.2 million...
4:05 PM May 24, 2018
FDA approves BioMarin's phenylketonuria drug
FDA approved Palynziq pegvaliase-pqpz from BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to treat...
3:58 PM May 24, 2018
Lawmakers introduce direct-to-consumer rebate bill
Reps. Doug Collins (R-Ga.) and Vicente Gonzalez (D-Texas) introduced a bill that would direct health plans...
3:33 PM May 24, 2018
Striatal dopamine signaling regulates glucose metabolism
Researchers at Academic Medical Center (AMC) found that dopamine signaling is a key regulator of systemic...
3:16 PM May 24, 2018
Antengene fills pipeline with Karyopharm deal
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) granted cancer company Antengene Corp. (Shanghai, China)...
2:58 PM May 24, 2018
Imbruvica, Gazyva combo meets in first-line CLL
AbbVie Inc. (NYSE:ABBV) said Imbruvica ibrutinib plus Gazyva obinutuzumab met the primary endpoint of...
2:33 PM May 24, 2018
Shifting Medicare Part B drugs to Part D saves nothing, CBO says
A Congressional Budget Office analysis of the Trump administration’s FY19 budget proposal concludes that...
2:28 PM May 24, 2018
miRNA-targeted circular single-stranded DNA to treat cancer
A Nankai University-based team developed a small circular single-stranded DNA molecule that inhibits...
About Biocentury
Contact
Support
Products & Solutions
Legal
- Follow Us
What is BioCentury?
BioCentury employs a fully integrated multimedia platform — including publications, video, online data solutions and conferences — to provide its audience with authoritative and up-to-date intelligence about corporate strategy, partnering, emerging technology, clinical data, public policy and the financial markets.